Search earnings tickers

LLY

2025Q4BMO

Eli Lilly and Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-02-04 · Fiscal end 2025-12-31 · Features as of 2026-02-03

← Earnings history

Street

Consensus EPS7.17

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.7%

IV front—

P/C full—

P/C front—

Features as of2026-02-03

Run-up

Close—

Ret 5d-3.5%

Ret 10d-3.6%

Ret 20d-3.7%

Ret 30d-5.1%

Print

Actual EPS

7.54Beat

Estimated EPS7.17

Actual revenue

19.3B

Surprise %+5.2%

Beat / missBeat

Beat streak 43

Beat streak 83

Reaction

1-day stock reaction+3.0%

Implied vs actual

Implied 2.7%Actual 7.1%

Gap reaction+7.1%

Day result+10.3%

Next-day upYes

Realized / IV2.66×

Post tape

Post 5d-8.3%

Post 10d-7.6%

Post volume7.1M

Vol ×10d2.32×

Vol ×20d2.35×

Post range4.6%

LLY

Pre-Earnings Data